P1420: PRE-CLINICAL PROOF OF CONCEPT DEMONSTRATES ROBUST ACTIVITY OF UCART20X22 DUAL CAR T-CELLS FOR THE TREATMENT OF B-CELL MALIGNANCIES

Bibliographic Details
Main Authors: B. Aranda Orgilles, I. Chion-Sotinel, S. Grudman, B. Mumford, C. Dixon, P. Duchateau, R. Galetto, A. Gouble, L. Poirot
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000848540.36064.91
_version_ 1797287257254658048
author B. Aranda Orgilles
I. Chion-Sotinel
S. Grudman
B. Mumford
C. Dixon
P. Duchateau
R. Galetto
A. Gouble
L. Poirot
author_facet B. Aranda Orgilles
I. Chion-Sotinel
S. Grudman
B. Mumford
C. Dixon
P. Duchateau
R. Galetto
A. Gouble
L. Poirot
author_sort B. Aranda Orgilles
collection DOAJ
first_indexed 2024-03-07T18:30:17Z
format Article
id doaj.art-c552cd31c99b44c0b73cf86a0fe06af9
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T18:30:17Z
publishDate 2022-06-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-c552cd31c99b44c0b73cf86a0fe06af92024-03-02T06:40:31ZengWileyHemaSphere2572-92412022-06-0161304130510.1097/01.HS9.0000848540.36064.91202206003-01304P1420: PRE-CLINICAL PROOF OF CONCEPT DEMONSTRATES ROBUST ACTIVITY OF UCART20X22 DUAL CAR T-CELLS FOR THE TREATMENT OF B-CELL MALIGNANCIESB. Aranda Orgilles0I. Chion-Sotinel1S. Grudman2B. Mumford3C. Dixon4P. Duchateau5R. Galetto6A. Gouble7L. Poirot81 Cellectis Inc, New York, United States of America2 Cellectis SA, Paris, France1 Cellectis Inc, New York, United States of America1 Cellectis Inc, New York, United States of America1 Cellectis Inc, New York, United States of America2 Cellectis SA, Paris, France2 Cellectis SA, Paris, France2 Cellectis SA, Paris, France2 Cellectis SA, Paris, Francehttp://journals.lww.com/10.1097/01.HS9.0000848540.36064.91
spellingShingle B. Aranda Orgilles
I. Chion-Sotinel
S. Grudman
B. Mumford
C. Dixon
P. Duchateau
R. Galetto
A. Gouble
L. Poirot
P1420: PRE-CLINICAL PROOF OF CONCEPT DEMONSTRATES ROBUST ACTIVITY OF UCART20X22 DUAL CAR T-CELLS FOR THE TREATMENT OF B-CELL MALIGNANCIES
HemaSphere
title P1420: PRE-CLINICAL PROOF OF CONCEPT DEMONSTRATES ROBUST ACTIVITY OF UCART20X22 DUAL CAR T-CELLS FOR THE TREATMENT OF B-CELL MALIGNANCIES
title_full P1420: PRE-CLINICAL PROOF OF CONCEPT DEMONSTRATES ROBUST ACTIVITY OF UCART20X22 DUAL CAR T-CELLS FOR THE TREATMENT OF B-CELL MALIGNANCIES
title_fullStr P1420: PRE-CLINICAL PROOF OF CONCEPT DEMONSTRATES ROBUST ACTIVITY OF UCART20X22 DUAL CAR T-CELLS FOR THE TREATMENT OF B-CELL MALIGNANCIES
title_full_unstemmed P1420: PRE-CLINICAL PROOF OF CONCEPT DEMONSTRATES ROBUST ACTIVITY OF UCART20X22 DUAL CAR T-CELLS FOR THE TREATMENT OF B-CELL MALIGNANCIES
title_short P1420: PRE-CLINICAL PROOF OF CONCEPT DEMONSTRATES ROBUST ACTIVITY OF UCART20X22 DUAL CAR T-CELLS FOR THE TREATMENT OF B-CELL MALIGNANCIES
title_sort p1420 pre clinical proof of concept demonstrates robust activity of ucart20x22 dual car t cells for the treatment of b cell malignancies
url http://journals.lww.com/10.1097/01.HS9.0000848540.36064.91
work_keys_str_mv AT barandaorgilles p1420preclinicalproofofconceptdemonstratesrobustactivityofucart20x22dualcartcellsforthetreatmentofbcellmalignancies
AT ichionsotinel p1420preclinicalproofofconceptdemonstratesrobustactivityofucart20x22dualcartcellsforthetreatmentofbcellmalignancies
AT sgrudman p1420preclinicalproofofconceptdemonstratesrobustactivityofucart20x22dualcartcellsforthetreatmentofbcellmalignancies
AT bmumford p1420preclinicalproofofconceptdemonstratesrobustactivityofucart20x22dualcartcellsforthetreatmentofbcellmalignancies
AT cdixon p1420preclinicalproofofconceptdemonstratesrobustactivityofucart20x22dualcartcellsforthetreatmentofbcellmalignancies
AT pduchateau p1420preclinicalproofofconceptdemonstratesrobustactivityofucart20x22dualcartcellsforthetreatmentofbcellmalignancies
AT rgaletto p1420preclinicalproofofconceptdemonstratesrobustactivityofucart20x22dualcartcellsforthetreatmentofbcellmalignancies
AT agouble p1420preclinicalproofofconceptdemonstratesrobustactivityofucart20x22dualcartcellsforthetreatmentofbcellmalignancies
AT lpoirot p1420preclinicalproofofconceptdemonstratesrobustactivityofucart20x22dualcartcellsforthetreatmentofbcellmalignancies